RE:CZO: buyers have the upper hand!Buyers may want to keep in mind though that last year in the 30 days leading up to Christmas this stock dropped over 20%. The two factors that weighed on czo last year, a lacklustre quarterly and tax loss selling are both present again this year. I will be buying, but not yet as I expect cheaper shares will be available.
And yes, it was great that beta glucan sales were up 400% but implicit in that fact is the fact that sales of avananthrimides, their other flagship product, must have fallen off a cliff to near zero. When one product goes up 400% and the total sales go up only 28% the other products must have been near zero. And, of course there was not a word of explanation in the report.
My main problem with this company is their communication with shareholders. We are coming up to a year since the date they inferred would see a deal on a functional drink. So, a year later, no deal seems imminent and not one word of explanation offered. If nothing else they could offer, 'we are still pursueing' or ' negotiations continue', anything.
So, i will again do a tax loss trade as the past two years have worked well. I look forward to the day this company does something that convinces me to be a long term holder.
Happy Friday.